Stay updated on ISB 830 Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of the study on ISB 830 for moderate to severe atopic dermatitis, with changes in the revision number and the removal of detailed study descriptions and inclusion/exclusion criteria.SummaryDifference7%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to ISB 830 Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ISB 830 Efficacy in Atopic Dermatitis Clinical Trial page.